English
Jubilant Pharmova Q1 Results
- BSE: 530019
- NSE: JUBLPHARMA
- ISIN: INE700A01033
- Sector: Biotechnology & Drugs
BSE
1,067.90
8.60 (0.81%)
8.60 (0.81%)Volume1.52 K
Updated: Wed 10 Dec, 2025 | 11:36:37
NSE
1,068.507.20 (0.68%)
7.20 (0.68%)Volume33.85 K
Updated: Wed 10 Dec, 2025 | 11:37:35
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Jubilant Pharmova Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,709.20 | 1,681.90 | 1.62% | 1,175.00 | 45.46% |
| Depreciation/ Amortization | 98.10 | 95.20 | 3.05% | 90.70 | 8.16% |
| Operating Income | 191.50 | 246.90 | -22.44% | 556.70 | -65.60% |
| Net Income | 102.90 | 153.60 | -33.01% | 482.10 | -78.66% |
| Other Operating Expenses Total | 401.80 | 366.70 | 9.57% | 365.60 | 9.90% |
| Net Income Before Taxes | 154.40 | 206.00 | -25.05% | 499.70 | -69.10% |
| Total Revenue | 1,900.70 | 1,928.80 | -1.46% | 1,731.70 | 9.76% |
| Selling/ General/ Admin Expenses Total | 591.10 | 590.60 | 0.08% | 552.90 | 6.91% |
| Diluted Normalized EPS | 6.47 | 9.82 | -34.11% | 6.34 | 2.08% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.